Page last updated: 2024-10-30

metformin and Injuries, Tendon

metformin has been researched along with Injuries, Tendon in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Inflammation is the first stage of this progression, becoming an appealing target of early therapeutic intervention."5.62Pharmacological activation of SIRT1 by metformin prevented trauma-induced heterotopic ossification through inhibiting macrophage mediated inflammation. ( Fan, C; He, Y; Li, J; Liu, W; Luo, G; Qian, Y; Sun, Z; Wang, F, 2021)
"Metformin is a commonly used antidiabetic drug."1.91Metformin suppressed tendon injury-induced adhesion via hydrogel-nanoparticle sustained-release system. ( Bing Luo, C; Jie Li, Z; Lang Zhou, Y; Liang Wang, H; Qian Yang, Q; Sun, J, 2023)
"Inflammation is the first stage of this progression, becoming an appealing target of early therapeutic intervention."1.62Pharmacological activation of SIRT1 by metformin prevented trauma-induced heterotopic ossification through inhibiting macrophage mediated inflammation. ( Fan, C; He, Y; Li, J; Liu, W; Luo, G; Qian, Y; Sun, Z; Wang, F, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Jie Li, Z1
Bing Luo, C1
Liang Wang, H1
Sun, J1
Qian Yang, Q1
Lang Zhou, Y1
Sun, Z1
Li, J1
Luo, G1
Liu, W1
He, Y1
Wang, F1
Qian, Y1
Fan, C1

Other Studies

2 other studies available for metformin and Injuries, Tendon

ArticleYear
Metformin suppressed tendon injury-induced adhesion via hydrogel-nanoparticle sustained-release system.
    International journal of pharmaceutics, 2023, Jul-25, Volume: 642

    Topics: Delayed-Action Preparations; Humans; Hydrogels; Metformin; Nanoparticles; Tendon Injuries; Tissue Ad

2023
Pharmacological activation of SIRT1 by metformin prevented trauma-induced heterotopic ossification through inhibiting macrophage mediated inflammation.
    European journal of pharmacology, 2021, Oct-15, Volume: 909

    Topics: Animals; Burns; Disease Models, Animal; Humans; Inflammation; Macrophages; Male; Metformin; Mice; Os

2021